DGAP-News: MediClin AG / Key word(s): Quarter Results MediClin AG: MediClin achieved a sales increase of EUR 4.2 mill. and aconsiderably improved operating result in the first quarter of 2015 30.04.2015 / 12:11 --------------------------------------------------------------------- MediClin achieved a sales increase of EUR 4.2 mill. and aconsiderably improved operating result in the first quarter of 2015 Offenburg, April 30, 2015 - In the first quarter of 2015 MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 136.6 mill. (Q1 2014: EUR 132.4 mill.) thus being EUR 4.2 mill. or 3.1% above the value of the first quarter 2014. On Group level material expenses were below the previous year's value, staff costs and depreciation and amortisation and other operating expenses increased against previous year's values. This development let to an improvement of the Groups operating result (Group-EBIT) of EUR 2.6 mill. from EUR -1.0 mill. to EUR 1.6 mill. compared with the previous year's quarter. The financial result was EUR -0,8 mill. (Q1 2014: EUR -1.0 mill.). The result after tax attributable to shareholders of MediClin AG of the first quarter 2015 improved by EUR 2.5 mill. from EUR -1.7 mill. to EUR 0.8 mill. Cash and cash equivalents were EUR 22.2 mill. (Q1 2014: EUR 11.1 mill.). In the first quarter of 2015 EUR 6.8 mill. (Q1 2014: EUR 5.0 mill.) were invested in fixed assets (brutto), thus being EUR 1.8 mill. above previous year's value but still in the line of the budget. The capital investment contain subsidies of EUR 0.4 mill. (Q1 2014: EUR 0.7 mill.). MediClin employed on average 6,463 employees (Q1 2014: 6,364 employees), calculated on the basis of full-time staff, in the first quarter of 2015. Development in the segments Sales of the post-acute segment amounted to EUR 79.2 mill. (Q1 2014: 74.0 mill.) being about EUR 5.2 mill. above the value of previous year's quarter. The newly established capacities in psychosomatic and in neurology and in the meantime also in geriatric have contributed to the sales increase just as in the second half-year of 2014. Sales in the acute segment were EUR 53.1 mill. (Q1 2014: EUR 54.4 mill.), it decreased by EUR 1.3 mill. Sales in the business area nursing care increased by EUR 0.1 mill. despite a lower number of places. Due to higher sales the operating result of the post-acute segment improved from EUR -1.8 mill. to EUR 0.7 mill. In the acute segment lower expenses let to a slight increase of the operating result from EUR 3.1 mill. to EUR 3.2 mill. Outlook The good start in the 2015 financial year let assume that the sales and earnings targets for the Group and the segments will be achieved. The interim report as of March 31, 2015 will be available in German and English from May 8, 2015 under www.mediclin.de. Über die MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,900 employees. MediClin ─ a company of the Asklepios Group --------------------------------------------------------------------- 30.04.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 351523 30.04.2015